We were also able to show that previous infection with SARS-CoV-2 in the interim, between the initial vaccination and the booster dose or after the booster, altered the immune response by increasing the anti-S1 antibody titer in all vaccinated individuals, regardless of the type of vaccine. The gene discussed is PSMD1; the disease is infection.